The National Institute of Mental Health awarded $186,839 to the Research Institute At Nationwide Children's Hospital on August 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) for a K23 career development grant supporting research into the static and dynamic neurocircuitry associated with fluctuations in non-suicidal self-injury. The award funds a longitudinal training study that will examine temporal variability in non-suicidal self-injury urges and behaviors by...
The National Institute of Mental Health awarded the University of Oregon $100,138 on February 1, 2027, to conduct longitudinal research characterizing the links between affective development and the emergence of depression symptoms in adolescent girls under the Mental Health Research Grants program (CFDA 93.242). The project analyzes six waves of data from the Longitudinal Transitions in Adolescent Girls Study spanning participants' second decade of life (N=174; age 10–13 at baseline). The...
The National Institute of Mental Health awarded the University of Wisconsin–Madison $1.644 million on June 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a mechanistic analysis of the transition from nonsuicidal to suicidal self-injury in adolescents. The research project will employ a multi-method longitudinal approach to follow adolescents aged 13–17 over a two-year period through February 28, 2031. The study aims to identify which factors predict...
The National Institute of Mental Health awarded the University of Colorado $430,163 on March 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to validate and translate a smartphone-based intervention monitoring approach (SBIM) for adolescents with mood disorders. The project develops a low-burden monitoring strategy to improve adherence to inter-session behavioral and mood tracking in adolescent mental health interventions. Study participants (N=33, ages 13–19 years)...
The National Institute of Mental Health awarded Oregon Research Behavioral Intervention Strategies, Inc. (doing business as Influents Innovations) $314,362 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to develop a digital evidence-based app for providers and teens addressing depression and subclinical depressive symptoms in youth. The project addresses the gap between the prevalence of depressive symptoms in adolescents and access to treatment. Cognitive...
The National Institute of Mental Health awarded Oregon Health & Science University $164,190 on December 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to fund a longitudinal study examining internalizing symptoms in adolescence through the lens of negative life events, emotion regulation dysfunction, and neurobiological mechanisms, with performance through July 31, 2029, at the Portland, Oregon campus. The research addresses the elevated prevalence and high...
The National Institute of Mental Health awarded the University of Oregon $745,000 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid implementation-effectiveness trial examining the feasibility and potential effectiveness of implementing Collaborative Assessment and Management of Suicidality for Teens (CAMS-4TEENS, or C4T) in Oregon school-based health centers. The project will deploy C4T, an evidence-based suicide intervention adapted from an...
The National Institute of Mental Health awarded the University of Georgia Research Foundation, Inc. $405,505 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate how daily social media engagement influences mood and coping among socially disconnected adolescents in rural and low-resource areas. The research comprises two stages. Stage 1 will collect one month of passive mobile-use data from 20 rural adolescents ages 13–17 to derive preliminary...
The National Institute of Mental Health awarded the University of Oregon $346,214 on September 28, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study examining linkages between neighborhood environment and depressive symptoms in adolescent girls, with investigation of how pubertal development and sleep quality mediate or moderate that relationship. The study leverages the first five waves of the ongoing Transitions in Adolescent Girls (TAG) study,...
The National Institute of Mental Health awarded the University of Wisconsin - Madison $747,342 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct an examination of social connection in suicide risk during the college transition. The project leverages multimodal, high-resolution assessments to elucidate how social connection across digital and physical contexts contributes to suicide risk during the transition to college. The research will collect...
The National Institute of Mental Health awarded the University of Oregon $159,560 on January 1, 2027, under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining the bidirectional dynamics of daily behavior and mood associated with adolescent non-suicidal self-injury using passive mobile sensing.
The research leverages passive smartphone data collection, including GPS technology and the Effortless Assessment of Risk States (EARS) platform, to observe associations between daily changes in movement, location, and mood fluctuations as potential indicators of emotional distress and non-suicidal self-injury risk. The project analyzes existing data from two ongoing studies: the Mobile Assessment for the Prediction of Suicide (MAPS) study, which includes 221 high-risk adolescent boys and girls, and the Transitions in Adolescent Girls (TAG) study, both of which employ continuous digital behavior data collection. The approach captures real-time behavioral data from adolescents' smartphones without requiring active participant input, addressing the gap in understanding how non-suicidal self-injury risk unfolds dynamically through moment-to-moment and day-to-day changes rather than relying on static diagnostic characteristics.
Work is performed in Eugene, Oregon. The project period runs from January 1, 2027 through December 31, 2029. This award carries the assistance type designation of Project Grant.